Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus A meta-analysis: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    9 August 2022

    • curprev 03:1003:10, 9 August 2022‎ 179.215.124.0 talk‎ 542 bytes +542‎ Created page with "== Target Article == Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus A meta-analysis; X Song, H Jia, Y Jiang, L Wang, Y Zhang, Y Muae; 2015; doi_citing_unknown == Retraction == RETRACTED ARTICLE: Management and academic practices to prevent higher education corruption – a case review of an international branch campus in Uzbekistan; Sia, Eng Kee; ; 2014-10-2 ; https://doi.org/10.1080/13583883..."
Retrieved from "https://wikicitingretracted.org/index.php?title=Anti-atherosclerotic_effects_of_the_glucagon-like_peptide-1_(GLP-1)_based_therapies_in_patients_with_type_2_Diabetes_Mellitus_A_meta-analysis"